These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16418422)

  • 41. Tiotropium versus salmeterol in COPD.
    Schembri S
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
    [No Abstract]   [Full Text] [Related]  

  • 42. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 43. Tiotropium in the management of chronic obstructive pulmonary disease.
    Rees PJ
    Eur Respir J; 2002 Feb; 19(2):205-6. PubMed ID: 11865999
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of anticholinergics in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Med; 2004 Dec; 117 Suppl 12A():24S-32S. PubMed ID: 15693640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tiotropium in chronic obstructive pulmonary disease.
    O'Connor AB
    N Engl J Med; 2009 Jan; 360(2):185-6; author reply 187. PubMed ID: 19137624
    [No Abstract]   [Full Text] [Related]  

  • 46. Tiotropium effective in treatment of COPD.
    Kripke C
    Am Fam Physician; 2005 Dec; 72(11):2219-20. PubMed ID: 16345146
    [No Abstract]   [Full Text] [Related]  

  • 47. [Dyspnea and quality of life in chronic obstructive pulmonary disease].
    Sanjuás C
    Arch Bronconeumol; 2002 Oct; 38(10):485-8. PubMed ID: 12372199
    [No Abstract]   [Full Text] [Related]  

  • 48. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
    Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
    Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The position of tiotropium in new treatment guidelines for chronic obstructive pulmonary disease].
    Koblížek V
    Vnitr Lek; 2013 Dec; 59(12):1073-80. PubMed ID: 24350939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption.
    Nakamura T; Nakanishi T; Haruta T; Shirasaka Y; Keogh JP; Tamai I
    Mol Pharm; 2010 Feb; 7(1):187-95. PubMed ID: 20020740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tiotropium: a new therapeutic option in asthma.
    Novelli F; Costa F; Latorre M; Malagrinò L; Celi A; Vagaggini B; Paggiaro P
    Monaldi Arch Chest Dis; 2013; 79(3-4):109-15. PubMed ID: 24761528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tiotropium: an inhaled anticholinergic for chronic obstructive pulmonary disease.
    Olin JL
    Am J Health Syst Pharm; 2005 Jun; 62(12):1263-9. PubMed ID: 15947126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
    Cole JM; Sheehan AH; Jordan JK
    Ann Pharmacother; 2012 Dec; 46(12):1717-21. PubMed ID: 23170031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
    Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
    Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide.
    Maselli DJ; Peters JI
    Ann Intern Med; 2016 Jan; 164(2):JC6. PubMed ID: 26784496
    [No Abstract]   [Full Text] [Related]  

  • 59. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S; Loke YK; Enright P; Furberg CD
    Postgrad Med J; 2014 Apr; 90(1062):205-7. PubMed ID: 24643260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic gains of prolonged bronchial dilatation in chronic obstructive pulmonary disease.
    Turino GM
    Ann Intern Med; 2005 Sep; 143(5):386-7. PubMed ID: 16144897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.